治疗性结肠直肠癌疫苗:新兴模式和转化机会
Palaniyandi Muthukutty1, Hyun Young Woo2,3, So Young Yoo1
1Institute of Nanobio Convergence, Pusan National University, Busan 46241, Republic of Korea.
Vaccines
|July 30, 2025
概括
治疗性疫苗通过增强抗瘤免疫力提供向性结肠直肠癌 (CRC) 治疗. 本综述探讨了新型疫苗平台和克服免疫逃避的策略,以改善CRC免疫治疗结果.
科学领域:
- 在瘤学瘤学.
- 免疫学 免疫学 免疫学
- 疫苗学 疫苗学 疫苗学
背景情况:
- 结肠直肠癌 (CRC) 仍然是一个重大的健康挑战,尽管传统治疗的进展.
- 目前的免疫疗法,如免疫检查点抑制剂,在很大比例的CRC患者 (非MSI-H) 中显示出有限的疗效.
- 对于新型治疗策略来增强CRC中抗瘤免疫力至关重要.
研究的目的:
- 提供对结直肠癌新兴治疗疫苗模式的全面审查.
- 讨论瘤免疫逃避和CRC中异质性的挑战.
- 突出CRC治疗疫苗的创新策略和临床发展.
主要方法:
- 关于结直肠癌治疗疫苗的当前研究的文献综述.
- 对各种疫苗平台的分析:,核酸,基于细胞的,载体驱动的和纳米技术.
- 讨论与CRC疫苗疗效相关的瘤微环境因素和免疫逃避机制.
主要成果:
- 治疗性疫苗是一种有针对性的方法,与传统疗法相比,系统毒性可能较低.
- 目前正在研究多种疫苗平台,每个平台都有独特的机制来刺激抗瘤免疫反应.
- 克服瘤免疫逃避和异质性的策略对于提高疫苗有效性至关重要.
结论:
- 治疗性疫苗是未来结直肠癌免疫治疗的有希望的途径.
- 克服瘤特异性免疫障碍是释放CRC疫苗充分潜力的关键.
- 持续的研究和临床转化对于将疫苗纳入标准CRC治疗方案至关重要.
更多相关视频
09:29Development and Maintenance of a Preclinical Patient Derived Tumor Xenograft Model for the Investigation of Novel Anti-Cancer Therapies
Published on: September 30, 2016
13.9K
07:59Portal Vein Injection of Colorectal Cancer Organoids to Study the Liver Metastasis Stroma
Published on: September 3, 2021
6.6K
相关概念视频
Cancer Vaccines
514
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
514
Tumor Immunotherapy
662
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
662
Targeted Cancer Therapies
7.8K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.8K
Microorganisms in Medicine and Therapeutics
345
Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.
345
Cancer Therapies
8.0K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
8.0K
Treatment Resistant Cancers
3.4K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.4K
